BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 21053145)

  • 1. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular delivery of peptide nucleic acids (PNAs).
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2014; 1050():193-205. PubMed ID: 24297361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption.
    Shiraishi T; Nielsen PE
    Nat Protoc; 2006; 1(2):633-6. PubMed ID: 17406290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular delivery and antisense effects of peptide nucleic acid conjugated to polyethyleneimine via disulfide linkers.
    Berthold PR; Shiraishi T; Nielsen PE
    Bioconjug Chem; 2010 Oct; 21(10):1933-8. PubMed ID: 20873710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
    Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
    Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
    Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
    Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
    Andaloussi SE; Lehto T; Lundin P; Langel U
    Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.
    Shiraishi T; Nielsen PE
    Artif DNA PNA XNA; 2011; 2(3):90-9. PubMed ID: 22567192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
    Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
    Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomolar cellular antisense activity of peptide nucleic acid (PNA) cholic acid ("umbrella") and cholesterol conjugates delivered by cationic lipids.
    Shiraishi T; Nielsen PE
    Bioconjug Chem; 2012 Feb; 23(2):196-202. PubMed ID: 22243634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
    J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent.
    Oh SY; Ju Y; Kim S; Park H
    Oligonucleotides; 2010 Oct; 20(5):225-30. PubMed ID: 20946011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (R/W)9.
    Cordier C; Boutimah F; Bourdeloux M; Dupuy F; Met E; Alberti P; Loll F; Chassaing G; Burlina F; Saison-Behmoaras TE
    PLoS One; 2014; 9(8):e104999. PubMed ID: 25127364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
    El Andaloussi S; Said Hassane F; Boisguerin P; Sillard R; Langel U; Lebleu B
    Methods Mol Biol; 2011; 764():75-89. PubMed ID: 21748634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal antisense effects of peptide-PNA conjugates.
    Good L; Awasthi SK; Dryselius R; Larsson O; Nielsen PE
    Nat Biotechnol; 2001 Apr; 19(4):360-4. PubMed ID: 11283595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.